• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AngioDynamics, Inc. - Common Stock (NQ:ANGO)

11.58 +0.53 (+4.80%)
Delayed Quote Updated: 4:00 PM EDT, Oct 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AngioDynamics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
AngioDynamics Announces Humana Medicare Advantage Coverage Policy Supporting Broader Access to NanoKnife® IRE for Prostate and Liver Cancer
October 14, 2026
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics (ANGO) Q1 2027 Earnings Call Transcript ↗
October 08, 2026
Medtech segment surges 13.2% as NanoKnife prostate procedures hit record volumes. 
Via The Motley Fool
Topics Earnings World Trade
News headline image
Why AngioDynamics Crashed Today ↗
October 08, 2026
AngioDynamics beats earnings, and drops 20%. 
Via The Motley Fool
AngioDynamics (NASDAQ:ANGO) Posts Narrower Q1 Loss, Holds Guidance Below Consensus ↗
October 08, 2026
Via Chartmill
AngioDynamics (NASDAQ:ANGO) Surges on Strong Quarterly Beat as Med Tech Segment Drives Growth ↗
July 14, 2026
Via Chartmill
AngioDynamics Inc (NASDAQ:ANGO) Beats Q3 Earnings Estimates and Raises Full-Year Guidance ↗
April 02, 2026
Via Chartmill
Traders are paying attention to the gapping stocks in Thursday's session. ↗
October 08, 2026
Via Chartmill
News headline image
AngioDynamics Q1 Earnings Call Highlights ↗
October 08, 2026
AngioDynamics (NASDAQ:ANGO) reported fiscal 2027 first-quarter revenue growth of 6.9% to $80.9 million, led by continued expansion in its Med Tech segment, while the company maintained its full-year... 
Via MarketBeat
Topics Earnings
News headline image
AngioDynamics Reports Fiscal Year 2027 First Quarter Financial Results; Continued Execution Drives Med Tech Growth and Profitability
October 08, 2026
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics Announces Appointment of Eric Honroth as President and Chief Executive Officer
October 08, 2026
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics and The PERT Consortium® Name Jacobi Hospital as ALPHA-PE Research Fund Award Recipient to Advance Real-World Pulmonary Embolism Evidence
October 02, 2026
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026
September 28, 2026
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics Sees MedTech Becoming Majority of Revenue in Fiscal 2027 ↗
August 11, 2026
AngioDynamics (NASDAQ:ANGO) expects its MedTech business to become the majority of company revenue in fiscal 2027, as the company continues a multiyear shift away from slower-growth legacy markets and... 
Via MarketBeat
News headline image
AngioDynamics to Participate in Upcoming Investor Conferences
July 28, 2026
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics (ANGO) Q4 2026 Earnings Call Transcript ↗
July 21, 2026
Med Tech revenue surged 16.7% as company shifts toward higher-margin products. 
Via The Motley Fool
Topics Earnings World Trade
News headline image
AngioDynamics Q4 Earnings Call Highlights ↗
July 14, 2026
AngioDynamics (NASDAQ:ANGO) reported higher fiscal fourth-quarter and full-year revenue, driven by continued growth in its med tech portfolio, while management said the company remains focused on... 
Via MarketBeat
Topics Earnings
News headline image
Full Transcript: AngioDynamics Q4 2026 Earnings Call ↗
July 14, 2026
AngioDynamics (NASDAQ:ANGO) released fourth-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. This content is powered by Benzinga APIs. For... 
Via Benzinga
Topics Earnings
News headline image
AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability
July 14, 2026
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026
June 30, 2026
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH)
June 17, 2026
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics Expands Patient Access to NanoKnife IRE for Prostate and Liver Cancer as Medicare Coverage Framework Takes Effect
May 28, 2026
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
May 27, 2026
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics Announces Two-Year PRESERVE Trial Data Demonstrating Durable NanoKnife IRE System Outcomes in Intermediate-Risk Prostate Cancer
May 13, 2026
From AngioDynamics, Inc.
Via Business Wire
News headline image
Med-Tech Resilience: AngioDynamics Pivot Pays Off with Double-Digit Growth and Profitability
April 02, 2026
The medical technology sector has long been a bellwether for the health of the broader economy and the efficiency of the healthcare system. Today, April 2, 2026, AngioDynamics (NASDAQ:ANGO) provided... 
Via MarketMinute
Topics Economy Retirement
News headline image
AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability
April 02, 2026
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference
March 31, 2026
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics to Report Fiscal 2026 Third Quarter Results on April 2, 2026
March 19, 2026
From AngioDynamics, Inc.
Via Business Wire
News headline image
Bastion Bets on Government Spending with $8 Million New Stake in Parsons ↗
February 27, 2026
Parsons delivers technology-driven solutions for defense, intelligence, and critical infrastructure clients across North America and beyond. 
Via The Motley Fool
News headline image
AngioDynamics to Present at the Leerink Partners Global Healthcare Conference
February 23, 2026
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform
February 19, 2026
From AngioDynamics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap